Cognoa

Cognoa is an early childhood development and pediatric behavioral health company dedicated to improving the lives of children and families by providing earlier and more equitable access to care. They have developed a digital diagnostic platform called Canvas Dx, the first and only FDA-authorized diagnostic solution for autism in children ages 1.5 to 6 years. Canvas Dx uses AI technology to analyze data from caregivers and clinicians to generate a highly accurate prediction of autism within days, not months or years.

Cognoa is committed to addressing the "waitlist crisis" that exists in the autism diagnosis process, where families often face long wait times and barriers to accessing essential services. Their technology aims to empower clinicians with the tools they need to diagnose or rule out autism quickly, enabling them to provide timely interventions and support to children and their families. Cognoa continues to develop digital diagnostics and therapeutics to further enhance the accessibility and effectiveness of care for children with developmental delays and behavioral health conditions.

Cognoa offers a variety of flexible work arrangements, including remote and hybrid options, to support employee wellbeing and career growth. This dedication to flexibility allows Cognoa to attract a diverse pool of talent while fostering a work environment that prioritizes individual needs and career progression.

Cognoa is an early childhood development and pediatric behavioral health company focused on developing digital diagnostics and therapeutics that enable earlier and more equitable access to care for children with developmental conditions like autism. They aim to transform the path to care by providing innovative, scientifically proven technologies and whole-child approach, ultimately improving the lives and outcomes of children and families.

Cognoa promotes a culture that is driven by a passionate commitment to improve the lives of children and families impacted by developmental delays, particularly autism. This mission unites a diverse team of clinicians, data scientists, engineers, and innovators who value collaboration, innovation, and a whole-child approach. The company fosters a supportive and inclusive environment where individuals are encouraged to bring their unique perspectives and talents to the table, working together to create earlier and more equitable access to care.

Cognoa recognizes the importance of diversity, equity and inclusion (DE&I) in building a robust and effective AI system, particularly in the field of autism diagnosis. They strive to train their AI to account for differences in gender, race, ethnicity, and socio-economic backgrounds to reduce the prevalent biases in autism diagnosis and ensure equitable access to care. They are committed to developing a diverse and inclusive workplace, with a strong representation of women, minorities, and individuals with disabilities.